Evolving field of cardio-oncology

Guo Li; Lijun Zhang; Meiyan Liu

doi:10.1016/j.cpt.2023.02.002

Evolving field of cardio-oncology

Cancer Pathog Ther. 2023 Feb 10;1(2):141-145. doi: 10.1016/j.cpt.2023.02.002. eCollection 2023 Apr.

Authors

Guo Li¹, Lijun Zhang¹, Meiyan Liu¹

Affiliation

¹ Department of Psycho-Cardiology, Beijing Anzhen Hospital, Beijing 100029, China.

Abstract

Therapy development for cancer and cardiovascular disease (CVD) to prolong lifespan makes the relationship between these two conditions more complex. Drug interactions in cardiology and oncology are associated with metabolism and drug transportation. Advances in biomarkers and imaging provide novel methods for detecting cardiotoxicity, including cardiac injury and inflammation. The new concept of CVD-related cancer risk is leading to a new direction of progression termed "reverse cardio-oncology."

Keywords: Cardio-oncology; Cardiotoxicity; Reverse cardio-oncology.

Publication types

Review